Unlike many other chemotherapy drugs that are administered intravenously, Xeloda® (capecitabine) is an oral medication that comes in the form of a tablet. It is taken by mouth twice a day for two weeks, followed by a one-week break. It is approved for the treatment of breast cancer and colorectal cancer.
Your dosage amount will depend on several factors, such as the severity of your cancer and other medications you are taking. You should take your dose within 30 minutes after a meal and at the same times every day to maintain an even level of the drug in your blood.
While most people tolerate this medication well, side effects are possible and may include nausea, diarrhea, and fatigue.
(For a more in-depth look at this oral medication, click Xeloda. This article also covers general dosing guidelines, safety precautions, and tips on effectively using this drug.)
Written by/reviewed by: Kristi Monson, PharmD;Arthur Schoenstadt, MD
Food and Drug Administration, Center for Drug Evaluation and Research. Electronic orange book: Approved drug products with therapeutic equivalence evaluations. FDA Web site. Available at: http://www.fda.gov/cder/ob/. Accessed May 7, 2007.
eMedTV serves only as an informational resource. This site does not dispense medical advice or advice of any kind.
Site users seeking medical advice about their specific situation should consult with their own physician. Click